Statera Therapeutics

Statera Therapeutics is developing a unique immunotherapy delivery platform addressing autoimmune diseases. Statera’s engineered polymer nanoparticle delivers multiple therapeutic payloads (antigen/proteins and small molecule drugs) to targeted cells in a preferred sequence to elicit proper immune response in autoimmunity.